000892293 001__ 892293
000892293 005__ 20211102141452.0
000892293 0247_ $$2doi$$a10.3390/cells10051038
000892293 0247_ $$2Handle$$a2128/27720
000892293 0247_ $$2pmid$$a33924987
000892293 0247_ $$2WOS$$aWOS:000654663800001
000892293 037__ $$aFZJ-2021-02002
000892293 082__ $$a570
000892293 1001_ $$00000-0002-4340-1117$$aRose, Michael$$b0$$eCorresponding author
000892293 245__ $$aThe ECM Modulator ITIH5 Affects Cell Adhesion, Motility and Chemotherapeutic Response of Basal/Squamous-Like (BASQ) Bladder Cancer Cells
000892293 260__ $$aBasel$$bMDPI$$c2021
000892293 3367_ $$2DRIVER$$aarticle
000892293 3367_ $$2DataCite$$aOutput Types/Journal article
000892293 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1635855063_13442
000892293 3367_ $$2BibTeX$$aARTICLE
000892293 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000892293 3367_ $$00$$2EndNote$$aJournal Article
000892293 520__ $$aThis study aims at characterizing the role of the putative tumor suppressor ITIH5 in basal-type bladder cancers (BLCA). By sub-classifying TCGA BLCA data, we revealed predominant loss of ITIH5 expression in the basal/squamous-like (BASQ) subtype. ITIH5 expression inversely correlated with basal-type makers such as KRT6A and CD44. Interestingly, Kaplan–Meier analyses showed longer recurrence-free survival in combination with strong CD44 expression, which is thought to mediate ITIH-hyaluronan (HA) binding functions. In vitro, stable ITIH5 overexpression in two basal-type BLCA cell lines showing differential CD44 expression levels, i.e., with (SCaBER) and without squamous features (HT1376), demonstrated clear inhibition of cell and colony growth of BASQ-type SCaBER cells. ITIH5 further enhanced HA-associated cell-matrix attachment, indicated by altered size and number of focal adhesion sites resulting in reduced cell migration capacities. Transcriptomic analyses revealed enrichment of pathways and processes involved in ECM organization, differentiation and cell signaling. Finally, we provide evidence that ITIH5 increase sensitivity of SCaBER cells to chemotherapeutical agents (cisplatin and gemcitabine), whereas responsiveness of HT1376 cells was not affected by ITIH5 expression. Thus, we gain further insights into the putative role of ITIH5 as tumor suppressor highlighting an impact on drug response potentially via the HA-CD44 axis in BASQ-type BLCA
000892293 536__ $$0G:(DE-HGF)POF4-524$$a524 - Molecular and Cellular Information Processing (POF4-524)$$cPOF4-524$$fPOF IV$$x0
000892293 588__ $$aDataset connected to DataCite
000892293 7001_ $$0P:(DE-Juel1)145698$$aNoetzel, Erik$$b1
000892293 7001_ $$00000-0002-5845-7973$$aKistermann, Jennifer$$b2
000892293 7001_ $$0P:(DE-Juel1)174333$$aEschenbruch, Julian$$b3
000892293 7001_ $$0P:(DE-HGF)0$$aRushrush, Sandra$$b4
000892293 7001_ $$0P:(DE-HGF)0$$aGan, Lin$$b5
000892293 7001_ $$0P:(DE-HGF)0$$aKnüchel, Ruth$$b6
000892293 7001_ $$00000-0002-4762-3964$$aGaisa, Nadine T.$$b7
000892293 7001_ $$00000-0002-8439-7994$$aDahl, Edgar$$b8
000892293 773__ $$0PERI:(DE-600)2661518-6$$a10.3390/cells10051038$$gVol. 10, no. 5, p. 1038 -$$n5$$p1038 -$$tCells$$v10$$x2073-4409$$y2021
000892293 8564_ $$uhttps://juser.fz-juelich.de/record/892293/files/cells-10-01038-v2.pdf$$yOpenAccess
000892293 909CO $$ooai:juser.fz-juelich.de:892293$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
000892293 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145698$$aForschungszentrum Jülich$$b1$$kFZJ
000892293 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)174333$$aForschungszentrum Jülich$$b3$$kFZJ
000892293 9131_ $$0G:(DE-HGF)POF4-524$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vMolecular and Cellular Information Processing$$x0
000892293 9130_ $$0G:(DE-HGF)POF3-553$$1G:(DE-HGF)POF3-550$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lBioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences$$vPhysical Basis of Diseases$$x0
000892293 9141_ $$y2021
000892293 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-08-29
000892293 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-08-29
000892293 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2020-08-29
000892293 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-08-29
000892293 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2020-08-29
000892293 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCELLS-BASEL : 2018$$d2020-08-29
000892293 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2020-08-29
000892293 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2020-08-29
000892293 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-08-29
000892293 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2020-08-29
000892293 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000892293 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000892293 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2020-08-29
000892293 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2020-08-29
000892293 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCELLS-BASEL : 2018$$d2020-08-29
000892293 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-08-29
000892293 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2020-08-29
000892293 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-08-29
000892293 920__ $$lyes
000892293 9201_ $$0I:(DE-Juel1)IBI-2-20200312$$kIBI-2$$lMechanobiologie$$x0
000892293 980__ $$ajournal
000892293 980__ $$aVDB
000892293 980__ $$aI:(DE-Juel1)IBI-2-20200312
000892293 980__ $$aUNRESTRICTED
000892293 9801_ $$aFullTexts